Perrigo Company plc

Perrigo Company plc

PRGO

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.53B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Perrigo Company plcPerrigo Company plc-0.810.5%-73%0.31.5
$19.42

Current Fair Value

85.7% upside

Undervalued by 85.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.53 Billion
Enterprise Value$5.01 Billion
Dividend Yield$1.16 (10.50%)
Earnings per Share$-10.29
Beta0.54
Outstanding Shares138,700,000

Return

Return on Equity-72.74%ROE
Return on Assets-22.77%
Return on Invested Capital-22.31%

Valuation & Multiples

P/E Ratio-0.84P/E Ratio
PEG-0.01PEG
Price to Sales0.35Price to Sales
Price to Book Ratio0.58Price to Book Ratio
Enterprise Value to Revenue1.2
Enterprise Value to EBIT-3.21
Enterprise Value to Net Income-3
Total Debt to Enterprise0.77
Debt to Equity1.53Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$0.33
Average shareholder expectation
Revenue Estimate
$1.03 B
Average shareholder expectation

Next Earnings Call

Expected Date
August 5, 2026
EPS Estimate
$0.39
Average shareholder expectation
Revenue Estimate
$1.01 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2895 15.02%
Total Calls878,700 11.96%
Total Puts254,400 42.04%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %109.22% 0.57%
Total Invested$1.62B 23.39%
Investors Holding339 3.00%

ESG Score

No data

About Perrigo Company plc

CEO: Murray Kessler

Relevant Senate Committees

Finance

This powerful committee controls taxation, trade policy, and entitlement spending (e.g., Medicare/Medicaid). Tax policy directly impacts profitability, trade policy affects global operations, and Medicare drug pricing decisions are critical for pharmaceutical companies like Perrigo.

Health, Education, Labor, and Pensions

This committee directly oversees the FDA, which is the primary regulatory body for pharmaceutical manufacturing, drug approvals, labeling, and safety. Its decisions are fundamental to Perrigo's ability to develop, produce, and sell its products.

Judiciary

This committee's oversight of antitrust laws and intellectual property (IP) is critical for a pharmaceutical company. It impacts M&A activity, generic drug competition, and patent enforcement, which are core to Perrigo's business strategy and profitability.

Commerce, Science, and Transportation

This committee's jurisdiction over the FTC is highly relevant. The FTC regulates advertising, marketing claims for over-the-counter (OTC) pharmaceutical products, and consumer protection, directly impacting Perrigo's product promotion and compliance.